This week in Drug Discovery (16 – 20 February)
News round-up for 16 – 20 February by Bruno Quinney, Content Team at DDW.
This week in DDW, an unexpected drug could help treat depression. Elsewhere, a new company is set to advance a cerebral palsy therapy.
The top stories:
Psychedelic drug could help treat depression
The psychedelic drug dimethyltryptamine (DMT) could help treat depression when combined with psychotherapy, The Guardian has reported.
Read more…
Higher dosage of Wegovy more effective for weight loss
The European Commission (EC) has approved a higher dosage of obesity drug Wegovy which has proved it can help adults lose weight more effectively.
Infliximab could restore disease response after drug holiday
Subcutaneous (SC) infliximab could restore and maintain disease response in most Crohn’s disease (CD) and ulcerative colitis (UC) patients, data shows.
New company to advance cerebral palsy therapy
A new regenerative medicine company is set to develop a novel cell and gene therapy targeting paediatric cerebral palsy (CP).
Read more…
Oesophageal cancer dataset made available for commercial use
Cancer Research Horizons has made one the largest oesophageal cancer datasets available for commercial licensing.
